Literature DB >> 9927685

Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes.

U Baron1, D Schnappinger, V Helbl, M Gossen, W Hillen, H Bujard.   

Abstract

A regulatory system for the in-depth study of gene functions in higher eukaryotic cells has been developed. It is based on the tetracycline-controlled transactivators and reverse tTA, which were remodeled to discriminate efficiently between two different promoters. The system permits one to control reversibly the activity of two genes, or two alleles of a gene, in a mutually exclusive way, and also allows one to abrogate the activities of both. This dual regulatory circuit, which can be operated by a single effector substance such as doxycycline, overcomes limitations of conventional genetic approaches. The conditional mutants that can now be generated will be useful for the study of gene function in vitro and in vivo. In addition, the system may be of value for a variety of practical applications, including gene therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927685      PMCID: PMC15342          DOI: 10.1073/pnas.96.3.1013

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

3.  Contacts between Tet repressor and tet operator revealed by new recognition specificities of single amino acid replacement mutants.

Authors:  R Baumeister; V Helbl; W Hillen
Journal:  J Mol Biol       Date:  1992-08-20       Impact factor: 5.469

4.  Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.

Authors:  S Efrat; D Fusco-DeMane; H Lemberg; O al Emran; X Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

5.  Proximity probing of Tet repressor to tet operator by dimethylsulfate reveals protected and accessible functions for each recognized base-pair in the major groove.

Authors:  V Helbl; C Berens; W Hillen
Journal:  J Mol Biol       Date:  1995-02-03       Impact factor: 5.469

Review 6.  Mechanisms underlying expression of Tn10 encoded tetracycline resistance.

Authors:  W Hillen; C Berens
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

7.  A chimeric transactivator allows tetracycline-responsive gene expression in whole plants.

Authors:  P Weinmann; M Gossen; W Hillen; H Bujard; C Gatz
Journal:  Plant J       Date:  1994-04       Impact factor: 6.417

8.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

9.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.

Authors:  D Resnitzky; M Gossen; H Bujard; S I Reed
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  A threonine to alanine exchange at position 40 of Tet repressor alters the recognition of the sixth base pair of tet operator from GC to AT.

Authors:  L Altschmied; R Baumeister; K Pfleiderer; W Hillen
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

View more
  28 in total

Review 1.  Regulatable systems: applications in gene therapy and replicating viruses.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  The impact of molecular biology on neuroscience.

Authors:  F Crick
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-12-29       Impact factor: 6.237

3.  Tet-system for the regulation of gene expression during embryonic development.

Authors:  L M Fedorov; O Y Tyrsin; V Krenn; E V Chernigovskaya; U R Rapp
Journal:  Transgenic Res       Date:  2001-06       Impact factor: 2.788

Review 4.  Inducible molecular switches for the study of long-term potentiation.

Authors:  Gaël Hédou; Isabelle M Mansuy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

5.  Simultaneous on/off regulation of transgenes located on a mammalian chromosome with Cre-expressing adenovirus and a mutant loxP.

Authors:  Saki Kondo; Aya Okuda; Hiromi Sato; Naoto Tachikawa; Miho Terashima; Yumi Kanegae; Izumu Saito
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

6.  Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.

Authors:  Ben Berkhout; Zongliang Gao; Elena Herrera-Carrillo
Journal:  Methods Mol Biol       Date:  2021

7.  Inducible DNA-loop formation blocks transcriptional activation by an SV40 enhancer.

Authors:  Stefan Ludwig Ameres; Lars Drueppel; Klaus Pfleiderer; Andreas Schmidt; Wolfgang Hillen; Christian Berens
Journal:  EMBO J       Date:  2005-01-13       Impact factor: 11.598

8.  Modulation of myosin A expression by a newly established tetracycline repressor-based inducible system in Toxoplasma gondii.

Authors:  M Meissner; S Brecht; H Bujard; D Soldati
Journal:  Nucleic Acids Res       Date:  2001-11-15       Impact factor: 16.971

9.  Altered activity, social behavior, and spatial memory in mice lacking the NTAN1p amidase and the asparagine branch of the N-end rule pathway.

Authors:  Y T Kwon; S A Balogh; I V Davydov; A S Kashina; J K Yoon; Y Xie; A Gaur; L Hyde; V H Denenberg; A Varshavsky
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

10.  A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain.

Authors:  K Akagi; M Kanai; H Saya; T Kozu; A Berns
Journal:  Nucleic Acids Res       Date:  2001-02-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.